Skip to main content

Table 1 Patients characteristics: mean ± standard deviation

From: For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time

Characteristics

All

Women

Men

Age

60 ± 17

  

Height (cm)

169 ± 10

  

Weight (kg)

69 ± 13.2

  

Body mass index (kg/m2)

24.2 ± 3.9

23.9 ± 4.2

24.4 ± 3.7

Injected activity (MBq)

220 ± 57

  

Whole-body PET/CT uptake time (min post-injection)

62 ± 4.6

  

PET/CT uptake time for 10 min LM acquisition (min post-injection)

83 ± 5.8

  

Tumor histology (n = 58)

 Non-small cell lung cancer

29

  

 Mesothelioma

1

  

 Non-Hodgkin lymphoma including:

14

  

  Diffuse B cell lymphoma

6

  

  Follicular lymphoma

4

  

  T cell lymphoma

2

  

  Mantle cell lymphoma

2

  

 Hodgkin disease

6

  

 Multiple Myeloma

1

  

 Esophageal cancers

3

  

 Pheochromocytoma

1

  

 Breast cancer

1

  

 Cervical-uterine cancer

1

  

 Ovarian cancer

1